STERIS Biological Indicator Recall: What Happens When a Sterilization Test Gives False Reassurance?

What happens when the test designed to confirm sterilization effectiveness may give a misleading result?

That's the concern behind a 2026 STERIS recall involving certain VERIFY biological indicators and steam sterilization test packs.

And for surgical professionals, the lesson extends well beyond the products themselves.

What Happened?

On August 31, 2026, STERIS began notifying customers about affected products. The FDA posted Class II recall records on October 2.

The concern involves the population of Geobacillus stearothermophilus spores used in biological indicators to monitor steam sterilization.

According to the FDA, the spore population in affected products may fall below the minimum specification during their shelf life.

Why does that matter?

A biological indicator could show no growth, suggesting that a sterilization cycle was effective, even when the cycle did not achieve the intended reduction in spores.

In other words, a reassuring test result may not always provide the reassurance the team expects.

Affected products include specific lots of VERIFY biological indicators and test packs, including models S3060, S3061, S3065, and S3069. Facilities must consult the recall notices for exact product and lot identification.

STERIS instructed customers to destroy affected inventory and indicated that eligible products would be replaced.

Why It Matters to Surgical Professionals

Sterile processing relies on multiple safeguards working together.

Equipment maintenance, validated processes, mechanical monitoring, chemical indicators, biological monitoring, documentation, and communication all contribute to the larger system.

But what happens when one of those monitoring tools becomes unreliable?

This recall reminds us that quality assurance depends on the reliability of the tools used to measure quality.

For sterile processing professionals, that means recall awareness and accurate product identification are essential.

For OR teams, it reinforces the importance of understanding how sterilization monitoring supports the instruments arriving in the surgical suite.

And for leadership, it highlights why recall information must reach the departments responsible for using affected products.

The FTLOS Takeaway

A passing indicator is only meaningful when the indicator itself is reliable.

The lesson isn't to distrust sterilization monitoring.

It's to recognize that monitoring products, like other medical devices, require oversight, traceability, and an effective recall-response system.

Patient safety depends on more than completing a process.

It depends on knowing that the process—and the tools used to verify it—are dependable.

Join the Conversation

For our sterile processing and OR professionals:

How does your organization communicate recalls involving sterilization monitoring products?

U.S. Food and Drug Administration. “Class 2 Device Recall VERIFY Dual Species SelfContained Biological Indicator.” FDA Medical Device Recalls, 2 Oct. 2026, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=222241.

U.S. Food and Drug Administration. “Class 2 Device Recall VERIFY Biological Steam Test Pack.” FDA Medical Device Recalls, 2 Oct. 2026, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=222243.